Clinical Trials Browser

Terminated × INDUSTRY × milademetan × Clear all

NCT04979442 2025-01-14

MANTRA

Phase 3 Terminated

175 enrolled 16 charts

Liposarcoma, Sarcoma

NCT03552029 2022-05-20

Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)

Phase 1 Terminated

10 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute